{"disease":{"id":"mixed-anxiety-depression","name":"mixed anxiety depression"},"drugs":{"marketed":[{"drug_id":"nardil","indication_name":"Mixed Anxiety and Depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nardil","generic_name":"Phenelzine Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Amine oxidase [flavin-containing] B","drug_class":"Monoamine Oxidase Inhibitor","quality_score":65,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05234281","title":"Concentrated Cross-disciplinary Group Intervention for Common Health Complaints (Including Post COVID-19 Fatigue)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Helse i Hardanger","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}